Ripretinib, also known as DCC-2618, is a potent, orally active and selective KIT/PDGFR inhibitor with potential antineoplastic activity.
DCC-2618 ( Ripretinib ), Bulk in stock, contact us by email for Bulk quotation. Kg scale intermediates are also be provided by custom synthesis.
For research use only. We do not sell to patients.